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A 54-yT-old man with a 22-yr history of Crohn's
disease was found to have a microscopic focus of im-
munoblastic lymphoma within a segment of small bowel
resected to relieve intestinal obstruction. There was no
other clinically evident disease. Thirty months later, he
developed axillary adenopathy with recurrent lym-
phoma of the same immunophenotype (IgA lambda)
and was given combination chemotherapy, with com-
plete clinical response. Lymphoma recurred 6 months
later in the axilla and progressed rapidly over the next
3 months, despite chemotherapy. He developed exten-
sive mediastinal, mesenteric, and retroperitoneal dis-
ease with malignant ascites and died 39 months after
diagnosis of the incidentally discovered bowel mucosal
primary tumor.
INTRODUCTION
Primary malignant lymphoma of the gastrointestinal
tract is uncommon (1. 2). Most occur in the stomach,
although, less often, the small bowel and colon are
involved. There is a known association between intes-
tinal adenoearcinoma and inflammatory bowel disease
{3. 4). However, primary intestinal lymphoma is rare
in these patients. Approximately 20 cases of malignant
lymphoma of the gastrointestinal tract arising in
Crohn's disease have been reported. There have been
reports of nearly twice that number of cases of colonic
malignant lymphoma in association with ulecrative
colitis (5). Of those with an adequate pathologic descrip-
tion, all have produced grossly evident tumors. The
present case is unique in that the primary small intes-
tinal lymphoma consisted of a minute focus confined
predominantly to the mucosa. which was discovered
incidentally in a segment of small bowel resected to
relieve chronic intermittent obstructive symptoms. Al-
though the patient remained well for 2'/? yr without
further therapy, his lymphoma subsequently relapsed
in axillary lymph nodes. This initially responded to
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chemotherapy, but eventually became widespread,
causing the patient's demise. We report on the clinical
and pathologic data of this case and review the previ-
ously reported cases of primary gastrointestinal lym-
phoma arising in the setting of Crohn's disease.
CASE REPORT
A 54-yr-old man with a 22-yr history of Crohn's
disease, who had been treated intermittently with cor-
ticosteroids and azulfadine and who had multiple prior
admissions for intermittent small bowel obstruction,
was admitted with malnutrition and recurrent symp-
toms of obstruction. Exploratory laparotomy was per-
formed, and a 3-foot segment of terminal ileum with
multiple foci of stricture and dilatations was resected.
Dilation of the proximal small bowel was noted, the
colon appeared normal, and the spleen was enlarged.
No adenopathy was evident. No further clinical staging
evaluation or treatment was rendered at that time.
The patient was well for 30 months, at which time,
he presented with right axillary adenopathy. A biopsy
was performed. Computerized tomography (CT) of the
chest and abdomen revealed no further adenopathy.
He was treated with MACOP-B (methotrexate. doxo-
rubicin. eyelophosphamide. vincristine. prednisone,
bleomycin) for 12 wk, resulting in complete resolution
of the adenopathy. Six months later, he developed
recurrent right axillary adenopathy which was again
biopsied and showed lymphoma. Repeat CT scans re-
vealed no other adenopathy. He was treated initially
with eyelophosphamide and doxorubicin, but his ade-
nopathy progressed on this therapy. His regimen was
changed to bleomyein. vincristine. etoposide. cytosine
arabinoside. procarbazine, and prednisone for one
cycle, but was stopped beeause of persistent thrombo-
cytopenia and leukopenia, presumed to result in part
from splenic sequestration. He subsequently underwent
splenectomy. In the perioperative period, his disease
rapidly progressed to involve the chest wall, as well as
the mediastinum, by CT scan. He resumed therapy
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with procarbazine, eloposide, cytosine arabinoside.
CCNU, and prednisone and was discharged from the
hospital. He was readmitted with dehydration and an-
asarca 1 month later. CT scan showed extensive retro-
peritoneal and mesenteric adenopathy. massive ascites,
and bilateral pleural effusions. The patient developed
sepsis and died several days after admission, 39 months
after diagnosis of primary bowel lymphoma.
Pathologic fmdings
Small bowel. The 70-cm length of terminal ileum
showed multiple dilatations and strictures with thick-
ening of the bowel wall, serosal edema, and cobbleston-
ing of the mucosa. No tumor was evident grossly. The
attached cecum was unremarkable. Histologic sections
of the small bowel showed active chronic idiopathic
inflammatory bowel disease characterized by increased
mucosal chronic inflammation with focal cryptitis and
crypt abscesses, as well as submucosal and serosal
lymphoid aggregates. Multiple deep fissuring ulcers
were seen. Although we saw no epithelioid granulomas,
the histology was consistent with active Crohn's disease
of the small bowel; there was no evidence of colonic
involvement.
In a random section of small bowel within the in-
flamed area, several adjacent villi were distended by a
monomorphic population of large lymphocytes with
abundant amphophilic cytoplasm and prominent nu-
cleoli {Fig. 1). Occasional tumor cells also were seen in
the adjacent submucosa. The lesion was approximately
2 mm in size. Multiple additional sections of this area,
as well as the remaining small bowel, failed to reveal
any similar foci. Eleven mesenteric lymph nodes
showed no evidence of lymphoma. Immunohistochem-
ical staining of parafTm-embedded sections showed
strong diffuse reactivity for IgA heavy and lambda light
chain within this focus (Fig. 2). This was consistent
I 11.. .:. l.uiiunohistochemical staining of the primary intestinal
immunoblastic lymphoma shows strong and diffuse reactivity for IgA
(it) and lambda light chain Ih). This is in contra.*;! to IgM (c) and
kappa (d). which react with occasional trapped plasma cells only,
(immunohistochemical stain, x l(X)).
FKI, I. Adjacent small intestinal villi expanded by a monotonous
intlltrate of immunoblastic lymphoma. This was a solitary, minute
focus. No further disease was evident in the adjacent bowei or lymph
nodes (hematoxylin and eosin. x 10).
FK,. 3. Ininiunublasuc lymphoma within an axillary Unipli node.
Morphologically and immunophenotypically. this was similar to the
prior focus within the resected small bowel (hematoxylin and eosin.
XI00).
with immunoblastic lymphoma of IgA, lambda type,
pathologic stage I.
Axillary lymph nodes. Both biopsies showed an en-
larged lymph node effaced by a similar population of
large lymphoid cells with amphophilic cytoplasm, ec-
centric nuclei, and prominent nucleoli consistent with
immunoblastic lymphoma (Fig. 3). Repeat immuno-
histochemistry on the ftrst lymph node biopsy again
showed a predominance of IgA and lambda expression
within this tumor. Flow cytometric analysis for lymph-
oid subset markers was not done on this biopsy because
of poor specimen preservation. Flow cytometry was
performed on tissue from the second lymph node bi-
opsy (with identical histology), and it showed that most
large lymphocytes were strongly positive for the com-
bination of B lymphocyte markers CD 19 and lambda
(88%); only a minority of CD 19 and kappa-positive
cells were seen {!%).
Spleen. The spleen weighed 1.1 kg and, on histologic
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section, showed only red pulp congestion. Tbere was
no evidence of involvement by malignant lymphoma.
DISCUSSION
The association of chronic idiopathic inflammatory
bowel disease (CIIBD) and gastrointestinal adenocar-
cinoma is well known (3. 4, 6, 7). The risk of colorectal
carcinoma in patients with uleerative colitis increases
with more extensive bowel involvement and colitis of
longer duration. It is estimated that the cumulative risk
of carcinoma after 25 yr of extensive colitis is 12% (8).
In Crohn's disease, prior reports emphasized that the
low risk of carcinoma is low; however, more recent
series have suggested that the frequency approaches
that of uleerative colitis (9).
Primary gastrointestinal lymphoma only rarely has
been reported in association with CIIBD. In a review
of primary colorectal lymphoma complicating CIIBD,
Shepherd et al. (5) reported on 32 cases associated with
uleerative colitis and six cases associated with Crohn's
disease. Cases of lymphoma arose in patients with
longstanding colonic disease (mean duration of colitis,
12 yr). Compared with sporadic cases of colorectal
lymphoma, those that arose in the setting of uleerative
colitis were more often multiple, left-sided, high grade,
and at an advanced stage at presentation. Of the 26
cases from which staging could be determined, 22 either
extended through the muscle wall or involved mesen-
teric lymph nodes.
In Table 1, we review the ciinicopathologic features
of 20 cases reported in the literature as Crohn'.s disease
complicated by malignant lymphoma. As In patients
with uleerative colitis, many of these patients had a
long history of inllammatory bowel disease prior to
development of lymphoma. although the majority had
disease for less than 10 yr. The patient we currently
report is at the extreme, with a 22-yr history of inter-
mittently active Crohn's disease.
This patient is also unique in thai the initial tumor
consisted of a single microscopic focus of immunoblas-
tic lymphoma confined predominantly to the mucosa,
with only a few cells extending into the submucosa.
The adjacent lymph nodes were not involved. Although
it was considered possible that this minute lesion rep-
resented the first manifestation of a generalized lym-
phoma. it appeared unlikely because of the lack o{
detectable disease at the time of initial work-up and the
subsequent 30-month disease-free hiatus. Of the 12
cases in the literature from which the extent of lym-
phoma could be determined, only one had disease
limited to the mucosa and submucosa. This case, re-
ported by Kini et al. (22). was a large, ulcerated super-
Hcial tumor in the stomach associated with noncaseat-
ing granulomas in the adjacent stomach and lymph
nodes. There was neither prior history of inflammatory
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bowel disease nor other evidence of Crohn's disease in
this patient. In the absence of follow-up, the diagnosis
of associated Crohn's disease may be questioned.
Hislologically, most of the cases reported in the lit-
erature have been classified as large cell non-Hodgkin's
lymphomas. Several have been classified only as high
grade B or T cell lymphomas. Of the four originally
classified as Hodgkin's disease, one was reclassified as
non-Hodgkin's lymphoma. The others probably also
represent pleomorphic non-Hodgkin's lymphomas.
Another case of immunobiastic lymphoma, histologi-
cally similar to the present case, was reported by Kwee
et al. (21). and arose in the sigmoid of a patient with a
4-yr history of Crohn's disease.
In our patient, the immunohistochemical typing of
the original small intestinal focus, as well as the recur-
rent axillar\' tumor, revealed the same immunopheno-
type, a predominance of IgA. and lambda staining in
the malignant cells. This is consistent with a B cell
lymphoma showing restricted immunoglobulin heavy
and light chain expression. This finding was supported
by the flow cytometric analysis on the second lymph
node recurrence, which again showed a predominant
population of B cells expressing lambda light chain.
Malignant lymphoma of the gastrointestinal tract
may not be suspected clinically in patients with a
history of Crohn's disease, because it may cause symp-
toms similar to those of active inflammatory bowel
disease. Gastrointestinal lymphoma has been discov-
ered at laparotomy in patients presenting with abdom-
inal pain, bloody diarrhea, or tenesmus (5, 14, 20).
Others may present with intestinal obstruction, fistuli-
zation, or stricture formation mimicking the eompli-
cations of active Crohn's disease (5, 12, 15, 19). In a
patient described by Wyburn-Mason (12), malignant
lymphoma obstructing a surgical anastomatic site was
discovered 7 yr after resection of an adjaeent segment
of ileum obstructed by active inflammatory bowel dis-
ease. When our patient's lymphoma was first diagnosed,
symptoms were referable to intestinal obstruction,
which was the result of active inflammatory bowel
disease. The focus of small bowel lymphoma was an
incidental microscopic finding.
As in our patient, most of those reported in the
literature developed lymphoma either within active in-
flammatory' bowel disease or at the site of prior activity.
This suggests ihat chronic inflammation and stimula-
tion of the immune response may provoke malignani
degeneration, nol only of the damaged and regenerating
epithelium, but also of the responding lymphocytes.
This is analogous to the situation in the small intestine
in patients with gluten-sensitive enteropathy. Chronic
lymphocytie inflammation and mucosal injury result
not only in malabsorption but, also, are associated with
July 1992 PRIMARY INTESTINAL LYMPHOMA IN CROHN'S DISEASE 897
TABLE I











































































































































* RCS. reticulum cell sarcoma; LS, lymphosarcoma,
t A. limited to the mucosa and submucosa; B, extending into or through the muscularis propria; C. involving mesenteric lymph nodes.
X NG. not given,
IS This case was originally reported as Hodgkin's disease. On rereview by Shepherd (5). it was reclassified as a high-grade B cell non-Hodgkin's
lymphoma.
II Case rereviewed by Shepherd (5).
an increased risk of stnall intestinal adenocarcinoma
and malignant lymphoma (25),
In summary, this is a unique case of a patient with a
long history of Crohn's disease who was found lo have
a microscopic focus of immunoblastic lymphoma in a
porlioti of small bowel resected for relief of bowel
obstruction. Although it remained inapparent for many
months after surgery, it eventually recurred in axillary
lymph nodes with an identical immunophenotype and.
despite chemotherapy, later disseminated, resultitig in
the patient's death.
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